4//SEC Filing
McGrath Yvonne 4
Accession 0001209191-23-018017
CIK 0001808865other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 7:54 PM ET
Size
5.5 KB
Accession
0001209191-23-018017
Insider Transaction Report
Form 4
McGrath Yvonne
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-09+130,000→ 130,000 totalExercise: $16.66Exp: 2033-03-09→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over four years, with 25% vesting on March 9, 2024 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Issuer.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816213
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 7:54 PM ET
- Size
- 5.5 KB